Immunitybio Strengthens Balance Sheet With $100 Million Of Financing Transactions Including $75 Million Of Non-Dilutive Financing To Support Global Expansion And Advancement Of Broader Immunotherapy Pipeline
IMMUNITYBIO STRENGTHENS BALANCE SHEET WITH $100 MILLION OF FINANCING TRANSACTIONS INCLUDING $75 MILLION OF NON-DILUTIVE FINANCING TO SUPPORT GLOBAL EXPANSION AND ADVANCEMENT OF BROADER IMMUNOTHERAPY PIPELINE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.